Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma—a “real world” study

Narendranath Epperla, Mehdi Hamadani, Amanda F. Cashen, Kwang W. Ahn, Eunhye Oak, Abraham S. Kanate, Oscar Calzada, Jonathon B. Cohen, Luke Farmer, Nilanjan Ghosh, Michael Tallarico, Chadi Nabhan, Luciano J. Costa, Vaishalee P. Kenkre, Parameswaran N. Hari, Timothy S. Fenske